| 1 | Name: | Dr. Joseph L. Goldstein | |
| Institution: | University of Texas Southwestern Medical Center | ||
| Year Elected: | 1987 | ||
| Class: | 2. Biological Sciences | ||
| Subdivision: | 201. Molecular Biology and Biochemistry | ||
| Residency: | Resident | ||
| Living? : | Living | ||
| Birth Date: | 1940 | ||
Joseph Goldstein is currently Chairman of the Department of Molecular Genetics at the University of Texas Southwestern Medical Center at Dallas and Julie and Louis A. Beecherl, Jr. Distinguished Chair in Biomedical Research and Paul J. Thomas Chair in Medicine. In 1985, he was named Regental Professor of the University of Texas. Together with his colleague Dr. Michael S. Brown, Dr. Goldstein has received a number of awards for their discovery of receptors that control cholesterol metabolism, including the Lasker Award in Basic Medical Research (1985), Nobel Prize in Physiology or Medicine (1985), National Medal of Science (1988) and Albany Medical Center Prize in Medicine and Biomedical Research (2003). Dr. Goldstein is a member of the U.S. National Academy of Sciences, American Philosophical Society, and the Institute of Medicine. He is also a Foreign Member of the Royal Society (London) and has received Doctor of Science honorary degrees from numerous institutions, including University of Chicago, University of Paris and The Rockefeller University. Dr. Goldstein is a past president of the American Society for Clinical Investigation (1985-86) and was a member of the Governing Council of the U.S. National Academy of Science (1991-94). He was also a Non-Resident Fellow of the Salk Institute (1983-1994) and served as Chairman of the Medical Advisory Board of the Howard Hughes Medical Institute (1995-2002). He has also served as a member of the editorial boards of Cell, Annual Review of Genetics, Journal of Biological Chemistry, Arteriosclerosis, Science and the Proceedings of the National Academy of Science. Dr. Goldstein is currently Chairman of the Albert Lasker Medical Research Awards Jury and is a member of the Boards of Trustees of the Howard Hughes Medical Institute and The Rockefeller University. He is a member of the Scientific Advisory Boards of the Welsh Foundations, Memorial Sloan-Kettering Cancer Center, Van Andel Institute, and the Dana-Farber Cancer Institute. He also currently serves on the Scientific Advisory Boards of several biotechnology companies (Genentech, Armgo, Five Prime) and is a member of the Board of Directors of Regeneron Pharmaceuticals. | |||